What Are Buffett, Dalio, and Druckenmiller So Worried About?

"This Will Be Worse Than The Great Depression, The Dot-Com Crash, And The 2008 Crisis Combined" According to Dan Ferris, who has predicted nearly every major market crisis of the last 25 years, a new crisis in the US economy could soon cost you 50% of your portfolio or more if you don't prepare your wealth now. Especially if you’re sitting on large gains.

Click here to see the new crisis that could abruptly end this current bull market.

REGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.48%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $105,638,222.64

Regeneron Pharmaceuticals Insider Trading History Chart

Regeneron Pharmaceuticals Share Price & Price History

^$749.51

▲ +11.51 (1.56%)

As of 11/25/2024 01:00 AM ET

Days: 30 | 90 | 365

"This Could Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined"

From Stansberry Research | Ad

What Are These Billionaire Investors Afraid Of? Billionaires Warren Buffett, Stanley Druckenmiller, George Soros, and David Tepper have all sold off massive U.S. stock positions, including shares of Nvidia, Apple, and Bank of America. Billionaire Ray Dalio, who runs one of the world’s most successful hedge funds, says, “Things are going to get worse for our economy.” What are these billionaires so worried about?

Click here to see why experts and insiders may be preparing for the biggest financial crisis of the

Regeneron Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/28/2024	Christopher R. Fenimore	CFO	Sell	5,680	$1,205.33	$6,846,274.40	15,305
8/7/2024	Jason Pitofsky	VP	Sell	487	$1,070.00	$521,090.00	4,204
7/11/2024	Joseph J. Larosa	EVP	Sell	1,866	$1,088.95	$2,031,980.70	37,937
7/1/2024	Arthur F. Ryan	Director	Sell	100	$1,059.24	$105,924.00	17,882
7/1/2024	Marion Mccourt	EVP	Sell	1,137	$1,047.11	$1,190,564.07	12,931
6/24/2024	Bonnie L. Bassler	Director	Sell	756	$1,062.00	$802,872.00	1,382
6/14/2024	Michael S. Brown	Director	Sell	1,535	$1,040.00	$1,596,400.00	1,382
6/11/2024	Leonard S. Schleifer	CEO	Sell	9,064	$1,015.43	$9,203,857.52	55,134
6/6/2024	Leonard S. Schleifer	CEO	Sell	787	$1,015.02	$798,820.74	64,198
6/5/2024	Bonnie L. Bassler	Director	Sell	827	$1,011.00	$836,097.00	1,382
5/28/2024	Michael S. Brown	Director	Sell	1,172	$974.86	$1,142,535.92	1,382
5/17/2024	Leonard S. Schleifer	CEO	Sell	22,830	$979.23	$22,355,820.90	466,877
5/14/2024	Leonard S. Schleifer	CEO	Sell	25,000	$979.25	$24,481,250.00	408,200
3/14/2024	Andrew J. Murphy	EVP	Sell	5,783	$956.47	$5,531,266.01	48,306
3/1/2024	Arthur F. Ryan	Director	Sell	100	$982.05	$98,205.00	18,282
3/1/2024	Marion Mccourt	EVP	Sell	358	$967.50	$346,365.00	13,431
2/26/2024	Bonnie L. Bassler	Director	Sell	854	$979.25	$836,279.50	1,382
2/22/2024	Joseph J. Larosa	EVP	Sell	1,000	$967.65	$967,650.00	37,543
2/7/2024	Joseph J. Larosa	EVP	Sell	1,000	$950.00	$950,000.00	38,543
2/5/2024	Marion Mccourt	EVP	Sell	1,000	$934.71	$934,710.00	13,789
2/1/2024	Arthur F. Ryan	Director	Sell	100	$954.22	$95,422.00	18,382
1/30/2024	Bonnie L. Bassler	Director	Sell	827	$959.00	$793,093.00	1,382
1/23/2024	Joseph L. Goldstein	Director	Sell	2,707	$950.00	$2,571,650.00	6,382
1/2/2024	George D. Yancopoulos	Insider	Sell	16,848	$900.00	$15,163,200.00	180,000
12/27/2023	Christopher R. Fenimore	SVP	Sell	2,448	$856.71	$2,097,226.08	14,372
12/27/2023	Michael S. Brown	Director	Sell	2,049	$898.00	$1,840,002.00	1,247
12/21/2023	Christopher R. Fenimore	SVP	Sell	1,680	$844.01	$1,417,936.80	17,070
12/1/2023	Arthur F. Ryan	Director	Sell	100	$817.30	$81,730.00	18,447
11/7/2023	Arthur F. Ryan	Director	Sell	100	$827.90	$82,790.00	18,547
11/1/2023	Marion Mccourt	EVP	Sell	1,000	$783.91	$783,910.00	19,803
10/13/2023	Huda Y. Zoghbi	Director	Sell	1,000	$850.00	$850,000.00	1,247
10/2/2023	Marion Mccourt	EVP	Sell	1,038	$827.00	$858,426.00	19,803
8/24/2023	Plew Daniel P Van	EVP	Sell	6,197	$841.71	$5,216,076.87	21,508
8/23/2023	Christine A. Poon	Director	Sell	12,280	$839.97	$10,314,831.60	2,037
8/23/2023	Robert E. Landry	CFO	Sell	223	$844.00	$188,212.00	31,699
8/22/2023	Neil Stahl	EVP	Sell	11,665	$840.98	$9,810,031.70	53,100
8/21/2023	Bonnie L. Bassler	Director	Sell	853	$829.00	$707,137.00	1,247
8/10/2023	Bonnie L. Bassler	Director	Sell	853	$789.00	$673,017.00	1,247
8/1/2023	Arthur F. Ryan	Director	Sell	100	$736.59	$73,659.00	18,647
7/3/2023	Arthur F. Ryan	Director	Sell	100	$716.88	$71,688.00	18,747
7/3/2023	Marion Mccourt	EVP	Sell	250	$710.09	$177,522.50	20,303
6/1/2023	Arthur F. Ryan	Director	Sell	100	$735.42	$73,542.00	18,847
6/1/2023	Marion Mccourt	EVP	Sell	250	$736.00	$184,000.00	20,553
4/21/2023	Michael S. Brown	Director	Sell	3,070	$798.42	$2,451,149.40	1,247
4/3/2023	Arthur F. Ryan	Director	Sell	100	$819.31	$81,931.00	19,047
4/3/2023	Marion Mccourt	EVP	Sell	1,100	$818.80	$900,680.00	20,803
3/27/2023	Robert E. Landry	CFO	Sell	183	$821.70	$150,371.10	32,929
3/24/2023	Bonnie L. Bassler	Director	Sell	1,240	$818.00	$1,014,320.00	1,247
3/23/2023	Christopher R. Fenimore	SVP	Sell	2,192	$806.47	$1,767,782.24	18,409
3/23/2023	George D. Yancopoulos	Insider	Sell	3,656	$804.26	$2,940,374.56	196,848
3/1/2023	Arthur F. Ryan	Director	Sell	100	$762.50	$76,250.00	19,147
3/1/2023	Marion Mccourt	EVP	Sell	1,100	$759.89	$835,879.00	20,803
2/7/2023	Marion Mccourt	EVP	Sell	1,000	$769.04	$769,040.00	22,079
2/6/2023	George D. Yancopoulos	Insider	Sell	13,189	$800.08	$10,552,255.12	200,504
2/6/2023	Joseph L. Goldstein	Director	Sell	3,613	$800.00	$2,890,400.00	6,247
2/6/2023	Robert E. Landry	CFO	Sell	752	$788.88	$593,237.76	32,105
2/3/2023	Bonnie L. Bassler	Director	Sell	1,021	$779.00	$795,359.00	1,247
2/3/2023	Robert E. Landry	CFO	Sell	739	$764.50	$564,965.50	32,105
1/27/2023	Michael S. Brown	Director	Sell	1	$747.00	$747.00	1,247
12/28/2022	N. Anthony Coles	Director	Sell	5,758	$714.11	$4,111,845.38	1,093
12/12/2022	Marion Mccourt	EVP	Sell	264	$730.17	$192,764.88	19,106
12/8/2022	Bonnie L. Bassler	Director	Sell	218	$779.00	$169,822.00	1,082
11/23/2022	Plew Daniel P Van	EVP	Sell	11,972	$740.75	$8,868,259.00	30,578
11/4/2022	Marion Mccourt	EVP	Sell	1,000	$727.82	$727,820.00	19,644
10/17/2022	Robert E. Landry	CFO	Sell	358	$739.50	$264,741.00	28,744
10/5/2022	Christopher R. Fenimore	SVP	Sell	1,844	$749.00	$1,381,156.00	16,425
10/3/2022	Christopher R. Fenimore	SVP	Sell	3,346	$724.00	$2,422,504.00	18,269
10/3/2022	Marc Tessier-Lavigne	Director	Sell	3,612	$718.00	$2,593,416.00	2,269
10/3/2022	Marion Mccourt	EVP	Sell	1,100	$705.39	$775,929.00	19,644
9/30/2022	Marc Tessier-Lavigne	Director	Sell	3,428	$698.00	$2,392,744.00	2,269
9/12/2022	Plew Daniel P Van	EVP	Sell	4,696	$716.38	$3,364,120.48	30,578
9/9/2022	Bonnie L. Bassler	Director	Sell	609	$741.00	$451,269.00	1,082
8/9/2022	Christine A. Poon	Director	Sell	15,000	$620.91	$9,313,650.00	1,872
8/5/2022	Neil Stahl	EVP	Sell	23,782	$612.61	$14,569,091.02	52,795
8/4/2022	Arthur F. Ryan	Director	Sell	10,453	$621.29	$6,494,344.37	18,408
8/1/2022	Marion Mccourt	EVP	Sell	1,100	$581.53	$639,683.00	19,644
7/1/2022	Marion Mccourt	EVP	Sell	1,100	$587.76	$646,536.00	19,644
5/2/2022	Arthur F. Ryan	Director	Sell	100	$650.78	$65,078.00	22,182
5/2/2022	Marion Mccourt	EVP	Sell	1,100	$656.97	$722,667.00	19,644
4/11/2022	Robert E. Landry	CFO	Sell	1,862	$734.06	$1,366,819.72	28,744
4/8/2022	Robert E. Landry	CFO	Sell	325	$737.79	$239,781.75	28,744
4/7/2022	Bonnie L. Bassler	Director	Sell	1,240	$725.00	$899,000.00	1,082
4/7/2022	Joseph J. Larosa	EVP	Sell	5,114	$721.10	$3,687,705.40	16,900
4/5/2022	Leonard S. Schleifer	CEO	Sell	4,461	$710.05	$3,167,533.05	465,922
4/1/2022	Arthur F. Ryan	Director	Sell	100	$692.81	$69,281.00	22,282
4/1/2022	Marion Mccourt	EVP	Sell	1,000	$701.82	$701,820.00	22,014
4/1/2022	Robert E. Landry	CFO	Sell	316	$695.81	$219,875.96
3/31/2022	Leonard S. Schleifer	CEO	Sell	2,886	$710.01	$2,049,088.86	465,922
3/30/2022	Michael S. Brown	Director	Sell	408	$699.00	$285,192.00
3/29/2022	Robert E. Landry	CFO	Sell	2,683	$687.90	$1,845,635.70
3/21/2022	Marc Tessier-Lavigne	Director	Sell	7,439	$690.00	$5,132,910.00
3/21/2022	Robert E. Landry	CFO	Sell	300	$693.00	$207,900.00
3/17/2022	Robert E. Landry	CFO	Sell	83	$686.00	$56,938.00
3/16/2022	Marc Tessier-Lavigne	Director	Sell	4,361	$675.00	$2,943,675.00
2/28/2022	George L. Sing	Director	Sell	2,000	$615.50	$1,231,000.00
2/25/2022	George L. Sing	Director	Sell	2,000	$621.00	$1,242,000.00
2/23/2022	Plew Daniel P Van	EVP	Sell	6,781	$613.99	$4,163,466.19
2/1/2022	Arthur F. Ryan	Director	Sell	100	$607.14	$60,714.00
2/1/2022	Marion Mccourt	EVP	Sell	1,000	$607.46	$607,460.00
12/13/2021	Marion Mccourt	EVP	Sell	344	$653.12	$224,673.28
12/13/2021	Robert E. Landry	CFO	Sell	116	$662.50	$76,850.00
12/10/2021	Andrew J. Murphy	EVP	Sell	7,122	$666.27	$4,745,174.94
12/10/2021	Robert E. Landry	CFO	Sell	781	$666.42	$520,474.02
12/9/2021	Marc Tessier-Lavigne	Director	Sell	3,784	$665.00	$2,516,360.00
12/1/2021	Arthur F. Ryan	Director	Sell	100	$637.53	$63,753.00
12/1/2021	Marion Mccourt	EVP	Sell	1,000	$639.13	$639,130.00

140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)

From Investors Alley | Ad

140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of an unique dividend strategy that works with giants like Tesla, Apple, and Amazon - at a 82% discount! Don't miss out on this special offer.

Click now to learn how to have the chance at 140% yields before time runs out!

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

83.31% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regeneron Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/25/2024	Synovus Financial Corp	1,881	$1.98M	0.0%	+3.4%	0.002%
11/25/2024	Tidal Investments LLC	6,350	$6.68M	0.1%	+8.7%	0.006%
11/25/2024	Blankinship & Foster LLC	1,980	$2.08M	0.3%	N/A	0.002%
11/25/2024	Wilmington Savings Fund Society FSB	1,810	$1.90M	0.0%	+193.4%	0.002%
11/25/2024	World Investment Advisors LLC	42,066	$44.22M	1.1%	N/A	0.038%
11/25/2024	Sanctuary Advisors LLC	35,938	$37.78M	0.2%	-20.7%	0.033%
11/25/2024	Pine Valley Investments Ltd Liability Co	5,303	$5.58M	0.3%	+19.0%	0.005%
11/22/2024	Sculati Wealth Management LLC	2,047	$1.97M	0.8%	+1.9%	0.002%
11/21/2024	Anchor Investment Management LLC	858	$0.90M	0.1%	+212.0%	0.001%
11/20/2024	Morse Asset Management Inc	4,807	$5.05M	1.1%	+0.9%	0.004%
11/20/2024	Virtu Financial LLC	6,054	$6.36M	0.4%	N/A	0.006%
11/20/2024	Bard Financial Services Inc.	230	$0.24M	0.0%	-9.8%	0.000%
11/18/2024	Soltis Investment Advisors LLC	711	$0.75M	0.1%	+4.1%	0.001%
11/18/2024	Rehmann Capital Advisory Group	538	$0.57M	0.0%	-14.7%	0.000%
11/18/2024	Teachers Retirement System of The State of Kentucky	7,977	$8.39M	0.1%	-48.5%	0.007%
11/18/2024	Toronto Dominion Bank	54,719	$57.52M	0.1%	+2.6%	0.050%
11/18/2024	Chiron Investment Management LLC	1,389	$1.46M	0.5%	-30.3%	0.001%
11/18/2024	Coldstream Capital Management Inc.	1,309	$1.36M	0.0%	+4.8%	0.001%
11/18/2024	Ashford Capital Management Inc.	1,483	$1.56M	0.2%	-5.7%	0.001%
11/16/2024	Geode Capital Management LLC	2,272,261	$2.38B	0.2%	-5.9%	2.068%
11/15/2024	Prestige Wealth Management Group LLC	82	$86K	0.0%	-19.6%	0.000%
11/15/2024	Vestcor Inc	21,590	$22.70M	0.7%	+3.1%	0.020%
11/15/2024	M&T Bank Corp	5,480	$5.76M	0.0%	+4.3%	0.005%
11/15/2024	LRI Investments LLC	175	$0.18M	0.0%	-29.7%	0.000%
11/15/2024	Public Employees Retirement System of Ohio	58,338	$61.33M	0.3%	-0.7%	0.053%
11/15/2024	Groupama Asset Managment	71,277	$74.93M	1.5%	+7.0%	0.065%
11/15/2024	Nomura Asset Management Co. Ltd.	86,004	$90.41M	0.3%	+4.5%	0.078%
11/15/2024	Y Intercept Hong Kong Ltd	9,425	$9.91M	0.6%	N/A	0.009%
11/15/2024	MML Investors Services LLC	5,315	$5.59M	0.0%	+13.9%	0.005%
11/15/2024	Orion Portfolio Solutions LLC	2,571	$2.70M	0.1%	-10.5%	0.002%
11/15/2024	World Investment Advisors LLC	42,066	$44.22M	0.2%	N/A	0.038%
11/15/2024	XTX Topco Ltd	806	$0.85M	0.1%	-23.7%	0.001%
11/15/2024	Zurich Insurance Group Ltd FI	63,641	$66.90M	0.6%	-31.1%	0.058%
11/15/2024	iSAM Funds UK Ltd	449	$0.47M	0.3%	N/A	0.000%
11/15/2024	National Bank of Canada FI	71,159	$74.81M	0.1%	+66.3%	0.065%
11/15/2024	iA Global Asset Management Inc.	13,186	$13.86M	0.2%	+1.5%	0.012%
11/15/2024	EP Wealth Advisors LLC	1,467	$1.54M	0.0%	+16.6%	0.001%
11/15/2024	Krensavage Asset Management LLC	353	$0.37M	0.2%	-95.5%	0.000%
11/15/2024	Insigneo Advisory Services LLC	836	$0.88M	0.1%	-21.1%	0.001%
11/15/2024	Kovitz Investment Group Partners LLC	3,691	$3.88M	0.0%	+54.6%	0.003%
11/15/2024	Wellington Management Group LLP	440,609	$463.19M	0.1%	-58.5%	0.401%
11/15/2024	Worldquant Millennium Advisors LLC	121,275	$127.49M	0.9%	N/A	0.110%
11/15/2024	Wahed Invest LLC	2,510	$2.64M	0.5%	+11.1%	0.002%
11/15/2024	State Street Corp	4,902,404	$5.15B	0.2%	+1.3%	4.461%
11/15/2024	Stevens Capital Management LP	452	$0.48M	0.1%	N/A	0.000%
11/15/2024	Stifel Financial Corp	48,245	$50.72M	0.1%	+7.3%	0.044%
11/15/2024	Quantinno Capital Management LP	7,473	$7.86M	0.1%	+59.9%	0.007%
11/15/2024	Royal London Asset Management Ltd.	43,675	$45.91M	0.1%	+2.7%	0.040%
11/15/2024	Pinpoint Asset Management Ltd	2,108	$2.22M	0.5%	+5.0%	0.002%
11/15/2024	Polar Asset Management Partners Inc.	400	$0.42M	0.0%	-69.2%	0.000%
11/15/2024	Mission Creek Capital Partners Inc.	1,439	$1.51M	0.4%	+2.0%	0.001%
11/15/2024	Morse Asset Management Inc	4,819	$5.07M	1.1%	+1.2%	0.004%
11/15/2024	IHT Wealth Management LLC	701	$0.74M	0.0%	+17.2%	0.001%
11/15/2024	Integrated Wealth Concepts LLC	748	$0.79M	0.0%	+40.1%	0.001%
11/15/2024	Investment Management Corp of Ontario	3,587	$3.77M	0.1%	+50.3%	0.003%
11/15/2024	Itau Unibanco Holding S.A.	86	$90K	0.0%	+115.0%	0.000%
11/15/2024	Jacobs Levy Equity Management Inc.	23,591	$24.80M	0.1%	+76.3%	0.021%
11/15/2024	Janus Henderson Group PLC	98,134	$103.18M	0.1%	-2.3%	0.089%
11/15/2024	HighTower Advisors LLC	33,025	$34.60M	0.0%	-7.2%	0.030%
11/15/2024	Chevy Chase Trust Holdings LLC	238,379	$250.59M	0.8%	-1.4%	0.217%
11/15/2024	Cinctive Capital Management LP	2,973	$3.13M	0.2%	-69.3%	0.003%
11/15/2024	Ascent Group LLC	470	$0.49M	0.0%	-6.9%	0.000%
11/15/2024	Beacon Investment Advisory Services Inc.	27,186	$28.58M	1.2%	+0.7%	0.025%
11/15/2024	Benjamin Edwards Inc.	3,137	$3.30M	0.0%	+12,448.0%	0.003%
11/15/2024	Atom Investors LP	259	$0.27M	0.0%	-9.1%	0.000%
11/15/2024	Bamco Inc. NY	4,500	$4.73M	0.0%	N/A	0.004%
11/15/2024	Paloma Partners Management Co	625	$0.66M	0.0%	-1,789.2%	0.001%
11/15/2024	Kestra Investment Management LLC	616	$0.65M	0.0%	+48.1%	0.001%
11/15/2024	FSA Wealth Management LLC	25	$26K	0.0%	N/A	0.000%
11/15/2024	Mark Sheptoff Financial Planning LLC	100	$0.11M	0.1%	-25.9%	0.000%
11/15/2024	Erste Asset Management GmbH	40,639	$42.48M	0.5%	N/A	0.037%
11/14/2024	Bellevue Group AG	26,776	$28.15M	0.5%	-17.1%	0.024%
11/14/2024	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	18,083	$19.01M	0.1%	-12.5%	0.016%
11/14/2024	Edgestream Partners L.P.	347	$0.37M	0.0%	-93.3%	0.000%
11/14/2024	Caisse DE Depot ET Placement DU Quebec	194,625	$204.60M	0.4%	+40.2%	0.177%
11/14/2024	Fred Alger Management LLC	8,821	$9.27M	0.0%	-20.7%	0.008%
11/14/2024	Captrust Financial Advisors	9,130	$9.60M	0.0%	+3.4%	0.008%
11/14/2024	Atlantic Union Bankshares Corp	2,267	$2.38M	0.1%	+9.8%	0.002%
11/14/2024	Rockefeller Capital Management L.P.	98,004	$103.02M	0.3%	-1.1%	0.089%
11/14/2024	Martingale Asset Management L P	21,711	$22.82M	0.5%	-17.1%	0.020%
11/14/2024	Hantz Financial Services Inc.	73	$77K	0.0%	+87.2%	0.000%
11/14/2024	Vinva Investment Management Ltd	2,597	$2.71M	0.1%	-28.9%	0.002%
11/14/2024	Public Sector Pension Investment Board	4,341	$4.56M	0.0%	+13.0%	0.004%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	755,112	$793.80M	0.2%	-10.9%	0.687%
11/14/2024	Fiduciary Trust Co	8,522	$8.96M	0.1%	+0.3%	0.008%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	139,749	$146.91M	0.4%	-3.5%	0.127%
11/14/2024	FORA Capital LLC	1,184	$1.25M	0.1%	-78.1%	0.001%
11/14/2024	MetLife Investment Management LLC	27,967	$29.40M	0.2%	-2.5%	0.025%
11/14/2024	RPg Family Wealth Advisory LLC	5,991	$6.30M	1.8%	+2.8%	0.005%
11/14/2024	BNP Paribas	1,733	$1.82M	0.1%	+16.3%	0.002%
11/14/2024	Healthcare of Ontario Pension Plan Trust Fund	20,609	$21.67M	0.1%	+107.1%	0.019%
11/14/2024	Cravens & Co Advisors LLC	1,305	$1.37M	1.1%	+5.8%	0.001%
11/14/2024	Blueshift Asset Management LLC	339	$0.36M	0.1%	N/A	0.000%
11/13/2024	Glenmede Trust Co. NA	6,095	$6.41M	0.0%	-11.7%	0.006%
11/13/2024	Bridgewater Associates LP	557	$0.59M	0.0%	-89.6%	0.001%
11/13/2024	Freedom Investment Management Inc.	756	$0.80M	0.1%	-13.5%	0.001%
11/13/2024	Townsquare Capital LLC	6,831	$7.18M	0.1%	+26.5%	0.006%
11/13/2024	Avestar Capital LLC	723	$0.76M	0.1%	+7.7%	0.001%
11/13/2024	Brooklyn Investment Group	520	$0.55M	0.2%	+7.4%	0.000%
11/13/2024	Quantbot Technologies LP	144	$0.15M	0.0%	N/A	0.000%

Data available starting January 2016

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Today's Range

Now: $749.51

$741.62

$757.86

50 Day Range

MA: $937.00

$738.00

$1,150.19

52 Week Range

Now: $749.51

$735.95

$1,211.20

Volume

1,196,249 shs

Average Volume

542,203 shs

Market Capitalization

$82.36 billion

P/E Ratio

18.55

Dividend Yield

N/A

Beta

0.15

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top insider investors include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Marion Mccourt (EVP)
Plew Daniel P Van (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Christopher R Fenimore (CFO)
Joseph L Goldstein (Director)
Jason Pitofsky (VP)
Christine A Poon (Director)
Bonnie L Bassler (Director)
Michael S Brown (Director)
Huda Y Zoghbi (Director)
N Anthony Coles (Director)
Learn More about top insider investors at Regeneron Pharmaceuticals.
Who are the major institutional investors of Regeneron Pharmaceuticals?: Regeneron Pharmaceuticals' top institutional investors include:
FMR LLC — 9.43%
State Street Corp — 4.46%
Geode Capital Management LLC — 2.07%
Loomis Sayles & Co. L P — 1.08%
International Assets Investment Management LLC — 0.80%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.69%
Learn More about top institutional investors of Regeneron Pharmaceuticals stock.
Which institutional investors are selling Regeneron Pharmaceuticals stock?: In the previous quarter, REGN stock was sold by these institutional investors:
Wellington Management Group LLP
FMR LLC
Geode Capital Management LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Loomis Sayles & Co. L P
Zurich Insurance Group Ltd FI
Massachusetts Financial Services Co. MA
BNP PARIBAS ASSET MANAGEMENT Holding S.A.
During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:
Leonard S Schleifer (CEO)
George Yancopoulos (Insider)
Neil Stahl (EVP)
Andrew J Murphy (EVP)
Joseph J Larosa (EVP)
Robert E Landry (CFO)
Marion Mccourt (EVP)
Plew Daniel P Van (EVP)
Arthur F Ryan (Director)
Christopher R Fenimore (SVP)
Christopher R Fenimore (CFO)
Joseph L Goldstein (Director)
Learn More investors selling Regeneron Pharmaceuticals stock.
Which institutional investors are buying Regeneron Pharmaceuticals stock?: During the last quarter, REGN stock was purchased by institutional investors including:
International Assets Investment Management LLC
Worldquant Millennium Advisors LLC
Icon Wealth Advisors LLC
State Street Corp
Caisse DE Depot ET Placement DU Quebec
Mizuho Securities USA LLC
Assenagon Asset Management S.A.
World Investment Advisors LLC